癌症中胸膜微环境重塑 癌症尾症作为检查点抑制剂有效性和毒性的决定因素
Run-Kai Huang1,2, Yan-Fang Xing3, Xiang-Yuan Wu1,2
1Department of Medical Oncology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Journal of cachexia, sarcopenia and muscle
|July 16, 2025
概括
癌症缓解症损害了胆小板功能,导致T细胞选择和自身抗体生产的改变. 这会影响癌症患者的免疫检查点抑制剂 (ICI) 疗效,影响治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 免疫检查点将自身免疫和癌症联系起来.
- 胸腺缩与自身免疫性炎症有关.
- 癌症缓解症对胸膜内置的影响及其临床意义尚不清楚.
研究的目的:
- 调查癌症缓解症对胸腺内置的影响.
- 确定缓解症诱导的胸膜变化的临床意义.
- 探索与免疫检查点抑制剂 (ICI) 治疗疗效的相关性.
主要方法:
- 单细胞测序,免疫光和流动细胞测量在正型肝细胞癌 (HCC) 的小鼠中.
- 在 cachectic HCC 鼠标模型中对胸膜变化的分析.
- 对接受抗PD-1/L1抗体治疗的癌症患者进行后续研究,以将血清自身抗体与ICI疗效相关联.
主要成果:
- 在HCC小鼠中,甲状腺硬化导致甲状腺纤维细胞不成熟,抗原处理受损,与甲状腺细胞的相互作用减少.
- 卡切克性小鼠表现出甲状腺髓降解和纤维细胞基因表达的改变,这表明T细胞负选择受损.
- 癌症卡赫西克性红色素原生细胞诱导了原生细胞死亡和减少了特定的髓性纤维细胞;在卡赫西克性小鼠和ICI治疗患者中观察到较高的自身抗体,与治疗结果相关.
结论:
- 癌症缓解症扰乱了髓纤维细胞的成熟,损害了T细胞的负性选择,并扩大了T细胞受体谱对抗受组织限制的抗原.
- 这些缓解症诱导的胸膜变化可能会调解ICI在癌症治疗中的不利和有利影响.
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


